Factor VII during warfarin treatment.
D000328:Adult; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D004591:Electrophoresis, Polyacrylamide Gel; D005167:Factor VII / Q000378:metabolism*; D005170:Factor X / Q000378:metabolism; D005260:Female; D006801:Humans; D007106:Immune Sera; D008297:Male; D008593:Menopause / Q000187:drug effects; D008598:Menstruation / Q000187:drug effects; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D009500:Neutralization Tests; D011517:Prothrombin Time; D011817:Rabbits / Q000276:immunology; D012737:Sex Factors; D013268:Stimulation, Chemical; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*; D013925:Thromboplastin / Q000378:metabolism; D013997:Time Factors; D014859:Warfarin / Q000494:pharmacology* / Q000627:therapeutic use
D007106:Immune Sera; D014859:Warfarin; D005167:Factor VII; D005170:Factor X; D013925:Thromboplastin